Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0012627250
Tue, 16.12.2025
HBM Healthcare Investments AG
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.12.2025
16.12.2025 / 17:45 CET/CEST
in CHF
Performance in %
15.12.2025
MTD
FYTD
CYTD
NAV
281.27
4.5
18.2
[ … ]
Mon, 15.12.2025
HBM Healthcare Investments AG
HBM Healthcare Investments, an investment company focused on the healthcare sector, has announced the signing of a binding agreement to sell a majority stake in Swixx Biopharma. As part of the transaction, HBM Healthcare Investments, together with the founders and other shareholders such as Mérieux Equity Partners, will sell a majority of their cur [ … ]
Mon, 08.12.2025
HBM Healthcare Investments AG
HBM Healthcare Investments AG
/ Key word(s): Acquisition/Partnership
Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million
08.12.2025 / 14:50 CET/CEST
HBM Healthcare Investments, an investment company focused on the healthcare sector, announces that the shareholders of its [ … ]
Mon, 01.12.2025
HBM Healthcare Investments AG
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
30.11.2025
01.12.2025 / 17:45 CET/CEST
in CHF
Performance in %
30.11.2025
MTD
FYTD
CYTD
NAV
269.16
3.1
13.2
[ … ]
Mon, 17.11.2025
HBM Healthcare Investments AG
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.11.2025
17.11.2025 / 17:47 CET/CEST
in CHF
Performance in %
15.11.2025
MTD
FYTD
CYTD
NAV
258.98
-0.8
9.0
[ … ]
Mon, 03.11.2025
HBM Healthcare Investments AG
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
31.10.2025
03.11.2025 / 17:47 CET/CEST
in CHF
Performance in %
31.10.2025
MTD
FYTD
CYTD
NAV
261.15
3.7
9.9
[ … ]
Fri, 24.10.2025
HBM Healthcare Investments AG
Profit of CHF 96 million despite unfavourable currency developments
Main profit drivers are acquisitions and clinical successes at public portfolio companies
Net asset value (NAV) up 6.1% and share price up 4.0%; discount to NAV at 28%
Returning investor interest and confidence in the biopharma sector
[ … ]
Thu, 16.10.2025
HBM Healthcare Investments AG
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.10.2025
16.10.2025 / 17:47 CET/CEST
in CHF
Performance in %
15.10.2025
MTD
FYTD
CYTD
NAV
256.16
1.7
7.9
[ … ]
Wed, 01.10.2025
HBM Healthcare Investments AG
HBM Healthcare Investments delivered a convincing performance in the second quarter of the 2025/2026 financial year, increasing its net asset value (NAV) per share by 16.4 per cent to CHF 251.78. This resulted in a quarterly profit of CHF 236 million, more than offsetting the primarily currency-related loss from the first quarter.
For [ … ]
Wed, 01.10.2025
HBM Healthcare Investments AG
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
30.09.2025
01.10.2025 / 17:47 CET/CEST
in CHF
Performance in %
30.09.2025
MTD
FYTD
CYTD
NAV
251.78
4.6
6.1
[ … ]
